Back to Rathbones Group PLC Rathbones Group PLC

IBRXIBRX
Showing 8 of 12 quarters

Position history for Rathbones Group PLCRathbones Group PLC's holdings in IMMUNITYBIO INC

Rathbones Group PLC holds 163,220 shares of IBRX (IMMUNITYBIO INC), worth $1.4M as of 2026-Q2. The position was decreased (-46.8% shares). IBRX represents 0.0% of Rathbones Group PLC's portfolio.

Current Value

$1.4M

Current Shares

163,220

Total Value Change

+$1.2M

Total Shares Change

+89,800

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
163,220
-46.8%
$1.4M0.0%$8.76
0
2026-Q1
Decreased
306,840
-5.0%
$2.4M0.0%$10.00
0
2025-Q4
Increased
322,840
+100.0%
$639,2220.0%$1.98
39
2025-Q3
Increased
161,420
+37.5%
$397,0930.0%$2.57
31
2025-Q2
Increased
117,420
+21.5%
$309,9880.0%$2.70
28
2025-Q1
Increased
96,620
+8.1%
$290,8260.0%$3.14
25
2024-Q4
Increased
89,420
+21.8%
$228,9150.0%$2.68
28
2024-Q3
Unchanged
73,420
0.0%
$273,1220.0%$3.93
0

Other major holders of IBRX: BlackRock, Inc., STATE STREET CORP, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used